Raymond James & Associates Sensei Biotherapeutics, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 20,000 shares of SNSE stock, worth $9,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 14,000
42.86%
Holding current value
$9,800
Previous $8,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SNSE
# of Institutions
22Shares Held
2.23MCall Options Held
0Put Options Held
0-
Ikarian Capital, LLC Dallas, TX650KShares$318,5000.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA619KShares$303,1900.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny216KShares$105,6300.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY173KShares$84,6890.0% of portfolio
-
Geode Capital Management, LLC Boston, MA163KShares$79,9380.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $15.1M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...